Amy E. Rose
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Cancer Research top 2%
- MicroRNA in disease regulation
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 5
- Cutaneous Melanoma Detection and Management 5
-
- Dermatologic Treatments and Research 2
- Cancer and Skin Lesions 1
- Co-authors
- Iman Osman (12 shared papers)Eva Hernando (5 shared papers)David J. Goldberg (2 shared papers)Jan Zakrzewski (3 shared papers)Douglas Hanniford (3 shared papers)Ilana Belitskaya‐Lévy (2 shared papers)Miguel F. Segura (2 shared papers)David Polsky (4 shared papers)
- Journals
- Dermatologic Surgery (2 papers)Journal of Translational Medicine (2 papers)Clinical Cancer Research (2 papers)Cancer (2 papers)Cancer Prevention Research (1 paper)
- Partner nations
- United StatesSwitzerlandSpain
In The Last Decade
Amy E. Rose
33 papers receiving 3.2k citations
Amy E. Rose's Hit Papers
Peers
Comparison fields: 5 of 73
- Oncology 717
- Cancer Research 402
- Molecular Biology 904
- Dermatology 94
- Pulmonary and Respiratory Medicine 155
Countries citing papers authored by Amy E. Rose
This map shows the geographic impact of Amy E. Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Rose more than expected).
Fields of papers citing papers by Amy E. Rose
This network shows the impact of papers produced by Amy E. Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Rose. The network helps show where Amy E. Rose may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy E. Rose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients Hit paper breakdown → | 2021 | 1332 |
| 2 | 2009 | 484 | |
| 3 | Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 Hit paper breakdown → | 2022 | 373 |
| 4 | 2010 | 188 | |
| 5 | 2013 | 95 | |
| 6 | 2010 | 93 | |
| 7 | 2018 | 78 | |
| 8 | 2018 | 77 | |
| 9 | 2011 | 59 | |
| 10 | 2011 | 52 | |
| 11 | 2010 | 50 | |
| 12 | 2010 | 45 | |
| 13 | 2021 | 44 | |
| 14 | 2009 | 43 | |
| 15 | 2024 | 43 | |
| 16 | 2021 | 22 | |
| 17 | 2012 | 21 | |
| 18 | 2005 | 17 | |
| 19 | 2011 | 17 | |
| 20 | 2010 | 16 |
About Amy E. Rose
Amy E. Rose is a scholar working on Oncology, Dermatology, Pulmonary and Respiratory Medicine, Cancer Research and Periodontics, having authored 34 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Cutaneous Melanoma Detection and Management (5 papers), MicroRNA in disease regulation (2 papers), Prostate Cancer Treatment and Research (2 papers), Dermatologic Treatments and Research (2 papers), Cancer and Skin Lesions (1 paper), Autoimmune and Inflammatory Disorders (1 paper) and Systemic Sclerosis and Related Diseases (1 paper). The work is most often cited by research in Oncology (717 citations), Cancer Research (402 citations), Molecular Biology (904 citations), Dermatology (94 citations) and Pulmonary and Respiratory Medicine (155 citations). Amy E. Rose has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include Iman Osman, Eva Hernando, David J. Goldberg, Jan Zakrzewski, Douglas Hanniford, Ilana Belitskaya‐Lévy, Miguel F. Segura, David Polsky, Richard L. Shapiro and Farbod Darvishian. Their work appears in journals such as Dermatologic Surgery, Journal of Translational Medicine, Clinical Cancer Research, Cancer and Cancer Prevention Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.